Tuesday, March 28, 2017

Interferon-beta producing stem cell-derived immune cell therapy on liver cancer

Induced pluripotent stem (iPS) cell-derived myeloid cells (iPS-ML) that produce the anti-tumor protein interferon-beta (IFN-beta) have been produced and analyzed. Using human iPS-ML in a mouse model, they found that the cells migrate to and deliver IFN-beta to liver tumors thereby reducing cancer proliferation and increasing survival time.



from Top Health News – ScienceDaily http://ift.tt/2o7gDOK
from Tumblr http://ift.tt/2nwvwsw

No comments:

Post a Comment